We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News Medica 2024 AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

Vascular Occluder Targets Wide Range of Peripheral Arteries

By HospiMedica International staff writers
Posted on 30 Dec 2020
A new platform provides interventional physicians with “one-and-done” solution for the occlusion of a peripheral arterial targets.

The Okami Medical LOBO (LOw-profile Braided Occluder) system combines neurovascular-derived HDBRAID technology with a patented design so as to create a highly occlusive structure for fast and efficient closure of blood vessels throughout the body. HDBRAID allows braided devices to be made with wires less than 20 microns in diameter, about ¼ the thickness of a human hair. This results in over 5,000 pores, with four times greater pore density than conventional occluders, which significantly reduces flow and accelerates hemostasis and thrombosis.

Image: The LOBO 3-disc braided occluder system (Photo courtesy of Okami Medical)
Image: The LOBO 3-disc braided occluder system (Photo courtesy of Okami Medical)

Features include a dense pore structure for rapid occlusion of a wide range of vessels; microcatheter delivery with instantaneous mechanical detachment; excellent trackability, even in small, tortuous vessels; conformance to curved vessels and expansion to accessible anatomical locations; retrievability prior to release; high stability following placement; and no spinnaker effect. The system includes the LOBO-5, intended for use in 3-5 mm diameter vessels, and the LOBO-3, intended for use in 1.5-3 mm vessels. It is not indicated for use in blood vessels where crush or bend forces are anticipated, such as joint areas and superficial vasculature.

“Guided by world-class physician collaborators, Okami is committed to addressing numerous challenging aspects of peripheral vascular occlusion,” said Bob Rosenbluth, PhD, president and CEO of Okami Medical. “LOBO-3 and LOBO-5, to be followed by LOBO-7 and LOBO-9, are designed and built to enable fast, predictable and complete occlusion of a diverse set of vascular targets, without the need for multiple embolic devices.”

Peripheral vascular occlusion is intended for the treatment of hemorrhages, aneurysms, and tumor isolation, including nephroma, hematoma, and other vascular malformations, and uterine fibroids, among other conditions.

Related Links:
Okami Medical


New
Gold Member
X-Ray QA Meter
T3 AD Pro
Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
New
Transcatheter Heart Valve
SAPIEN 3 Ultra
New
Cannulating Sphincterotome
TRUEtome

Latest Surgical Techniques News

Endoscopic Surgical System Enables Remote Robot-Assisted Laparoscopic Hysterectomy

Novel Neural Interface to Help Diagnose and Treat Neurological Disorders with Minimal Surgical Risks

New Lens System for Endoscopes Offers Physicians Unprecedented View of Inside the Body